LT3800257T - Pangenotipiniai agentai nuo gripo virusų ir jų naudojimo būdai - Google Patents
Pangenotipiniai agentai nuo gripo virusų ir jų naudojimo būdaiInfo
- Publication number
- LT3800257T LT3800257T LTEP20208373.9T LT20208373T LT3800257T LT 3800257 T LT3800257 T LT 3800257T LT 20208373 T LT20208373 T LT 20208373T LT 3800257 T LT3800257 T LT 3800257T
- Authority
- LT
- Lithuania
- Prior art keywords
- genotypic
- pan
- methods
- same
- influenza virus
- Prior art date
Links
- 241000712461 unidentified influenza virus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662302548P | 2016-03-02 | 2016-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3800257T true LT3800257T (lt) | 2024-07-25 |
Family
ID=59743201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP20208373.9T LT3800257T (lt) | 2016-03-02 | 2017-03-01 | Pangenotipiniai agentai nuo gripo virusų ir jų naudojimo būdai |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10597658B2 (lt) |
| EP (3) | EP3800257B1 (lt) |
| JP (2) | JP7536272B2 (lt) |
| CN (1) | CN108778344A (lt) |
| CA (1) | CA3014776A1 (lt) |
| DK (1) | DK3800257T3 (lt) |
| ES (1) | ES2981765T3 (lt) |
| FI (1) | FI3800257T3 (lt) |
| HR (1) | HRP20240765T1 (lt) |
| HU (1) | HUE066977T2 (lt) |
| LT (1) | LT3800257T (lt) |
| PL (1) | PL3800257T3 (lt) |
| PT (1) | PT3800257T (lt) |
| RS (1) | RS65707B1 (lt) |
| WO (1) | WO2017151795A1 (lt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11339392B2 (en) | 2016-03-02 | 2022-05-24 | The Board Of Trustees Of The Leland Stanford Junior University | Pan-genotypic agents against influenza virus and methods of using the same |
| WO2021201996A1 (en) * | 2020-02-14 | 2021-10-07 | The Board Of Trustees Of The Leland Stanford Junior University | Pan-genotypic agents against respiratory viruses and methods of using the same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT69956A (en) | 1990-08-14 | 1995-09-28 | Isis Pharmaceuticals Inc | Methode for inhibition of influenza virus by antiseuse oligonucleotides |
| US20040242518A1 (en) | 2002-09-28 | 2004-12-02 | Massachusetts Institute Of Technology | Influenza therapeutic |
| US8357664B2 (en) * | 2004-10-26 | 2013-01-22 | Avi Biopharma, Inc. | Antisense antiviral compound and method for treating influenza viral infection |
| WO2006110688A2 (en) * | 2005-04-08 | 2006-10-19 | Nastech Pharmaceutical Company Inc. | Rnai therapeutic for respiratory virus infection |
| US20070161591A1 (en) * | 2005-08-18 | 2007-07-12 | University Of Massachusetts | Methods and compositions for treating neurological disease |
| CN100562342C (zh) * | 2006-01-17 | 2009-11-25 | 奥林格斯技术有限公司 | 防治流感病毒感染的寡核苷酸药物 |
| WO2007084359A2 (en) * | 2006-01-17 | 2007-07-26 | Oligos Etc., Inc. | Compositions and methods for the treatment of influenza infection |
| EP2076600A1 (en) * | 2006-10-18 | 2009-07-08 | Nastech Pharmaceutical Company Inc. | Nicked or gapped nucleic acid molecules and uses thereof |
| US20090042823A1 (en) | 2007-08-10 | 2009-02-12 | Mdrna, Inc. | Uses of broad spectrum rnai therapeutics against influenza |
| CA2729757A1 (en) * | 2008-07-01 | 2010-01-07 | The Johns Hopkins University | Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase |
| DK2607484T3 (en) * | 2008-10-27 | 2016-03-07 | Biomarin Technologies B V | Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-MRNA |
| JP5991922B2 (ja) * | 2009-11-13 | 2016-09-14 | サレプタ セラピューティクス， インコーポレイテッド | アンチセンス抗ウイルス性化合物およびインフルエンザウイルス感染を処置するための方法 |
| EP2519633B1 (en) * | 2009-12-29 | 2017-10-25 | CuRNA, Inc. | Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1 |
| JP5906237B2 (ja) * | 2010-06-01 | 2016-04-20 | エータイアー ファーマ， インコーポレイテッド | リジルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
-
2017
- 2017-03-01 HU HUE20208373A patent/HUE066977T2/hu unknown
- 2017-03-01 HR HRP20240765TT patent/HRP20240765T1/hr unknown
- 2017-03-01 EP EP20208373.9A patent/EP3800257B1/en active Active
- 2017-03-01 RS RS20240693A patent/RS65707B1/sr unknown
- 2017-03-01 PL PL20208373.9T patent/PL3800257T3/pl unknown
- 2017-03-01 DK DK20208373.9T patent/DK3800257T3/da active
- 2017-03-01 WO PCT/US2017/020241 patent/WO2017151795A1/en active Application Filing
- 2017-03-01 LT LTEP20208373.9T patent/LT3800257T/lt unknown
- 2017-03-01 EP EP24159464.7A patent/EP4389221A2/en active Pending
- 2017-03-01 EP EP17760733.0A patent/EP3423107A4/en not_active Withdrawn
- 2017-03-01 CN CN201780014078.0A patent/CN108778344A/zh active Pending
- 2017-03-01 CA CA3014776A patent/CA3014776A1/en active Pending
- 2017-03-01 JP JP2018543209A patent/JP7536272B2/ja active Active
- 2017-03-01 ES ES20208373T patent/ES2981765T3/es active Active
- 2017-03-01 FI FIEP20208373.9T patent/FI3800257T3/fi active
- 2017-03-01 US US16/081,818 patent/US10597658B2/en active Active
- 2017-03-01 PT PT202083739T patent/PT3800257T/pt unknown
-
2022
- 2022-10-07 JP JP2022162516A patent/JP2022176378A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3423107A1 (en) | 2019-01-09 |
| EP3423107A4 (en) | 2020-01-15 |
| US20190136242A1 (en) | 2019-05-09 |
| US10597658B2 (en) | 2020-03-24 |
| FI3800257T3 (fi) | 2024-06-19 |
| RS65707B1 (sr) | 2024-08-30 |
| JP2022176378A (ja) | 2022-11-25 |
| CN108778344A (zh) | 2018-11-09 |
| EP3800257B1 (en) | 2024-05-01 |
| WO2017151795A1 (en) | 2017-09-08 |
| PL3800257T3 (pl) | 2024-09-16 |
| HRP20240765T1 (hr) | 2024-09-13 |
| EP4389221A2 (en) | 2024-06-26 |
| DK3800257T3 (da) | 2024-06-24 |
| JP7536272B2 (ja) | 2024-08-20 |
| HUE066977T2 (hu) | 2024-09-28 |
| ES2981765T3 (es) | 2024-10-10 |
| CA3014776A1 (en) | 2017-09-08 |
| JP2019511471A (ja) | 2019-04-25 |
| EP3800257A1 (en) | 2021-04-07 |
| PT3800257T (pt) | 2024-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201900278B (en) | Variant adeno-associated viruses and methods of using | |
| IL271025A (en) | Multibiotic substances and methods of using them | |
| IL263818A (en) | Antibodies against Zika virus and methods of use | |
| ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
| EP3325097A4 (en) | COMPOSITIONS AND AGENTS AGAINST HEPATITIS B VIRUSES AND USES THEREOF | |
| EP3277819A4 (en) | Adeno-associated virus variants and methods of use thereof | |
| IL247870A0 (en) | The hemagglutinin antibodies against influenza b virus and methods of use | |
| GB2539350B (en) | Amyloid targeting agents and methods of using the same | |
| EP3119883A4 (en) | Influenza virus vectors and uses therefor | |
| ZA202104969B (en) | Compositions comprising 15-hepe and methods of using the same | |
| HK1245776A1 (zh) | 流感病毒複製抑制劑及其使用方法和用途 | |
| HK1231402A1 (zh) | 治療 型肝炎和 型肝炎病毒感染的方法 | |
| SG11201610443WA (en) | Influenza virus vaccines and uses thereof | |
| EP3309251A4 (en) | VIRAL VECTOR OF PARAINFLUENZA TYPE 2 HUMAN AND VACCINE | |
| HK1251616A1 (zh) | 用於預防和/或治療感染性疾病以及用於治療腫瘤疾病的減毒流感病毒載體 | |
| HK1247136A1 (zh) | 包含15-hepe的組合物和其使用方法 | |
| LT3800257T (lt) | Pangenotipiniai agentai nuo gripo virusų ir jų naudojimo būdai | |
| EP3157950A4 (en) | Influenza vaccines and methods of use thereof | |
| IL249704A0 (en) | Influenza virus vaccines and their uses | |
| IL249705B (en) | Influenza virus vaccines and their uses | |
| SG11201803115TA (en) | Brace member and method of assembling the same | |
| TWI560711B (en) | Fastening device and method of using the same | |
| GB201520019D0 (en) | The genome and self-evolution of AI | |
| TH1501007823A (th) | วิธีการเเละองค์ประกอบสำหรับวัคซีนเดงกีไวรัส |